Robbins Headache Clinic

Lawrence Robbins, M.D.
Brooke Bassett

For more than 25 years, headache sufferers in the Chicago area have found relief from their pain, thanks to our cutting-edge treatment based on the latest advancements in the field. Dr. Larry Robbins, M.D., and Nurse Practitioner Brooke Phenicie, NP-C, use a comprehensive combination of remedies for migraines, tension headaches and cluster headaches. To start your individualized treatment plan, call and make an appointment.

2610 Lake Cook Road, Suite 160
Riverwoods, IL 60015
847.374.9399

Headache 2013

"NEW BOOK FROM DR. ROBBINS: ADVANCED HEADACHE THERAPY(ON AMAZON)

Treatment of headache at all ages. Hundreds of clinical tips/pearls. What to do when nothing works. Psychological conditions that often accompany severe headaches. Cutting edge medications and non-medicine approaches."

Hailed as "...the #1 resource for what to do for those with very difficult to treat headaches"....

View Dr. Robbins' Curriculum Vitae
in PDF Format

Click Here

Medical Expert in Pain Management, Headache, Concussion and Opioid Use

  • Deposition and Trial
  • Expert Consultation
  • Litigation Support

New on Our Blog ...

Genetic Link Found for Migraine and Stroke

Researchers and health professionals have known for some time that migraine and stroke are linked. New research indicates that both disorders share a genetic link. Study authors, led by Rainer Malik, PhD, of the University Hospital of Bordeaux, France, reviewed data from more than 23,000 migraineurs and 94,000 controls, and 12,000 people who had had […]

Read more...

Tension-Type Headache Related to Neck Strength

A recent Danish study has found that compared to a control group, patients who experience tension-type headache have decreased neck strength and also have less shoulder strength. Researchers say that when neck extensor muscles are weak, the flexor muscles over compensate and may pull the head forward contributing to headache. Researchers, led by Bjarne H. […]

Read more...

Study Looks at Link Between Insomnia in Migraineurs and Anxiety and Depression

This study, conducted at Sacred Heart Hospital at Hallym Univesity in South Korea investigated the association of insomnia, anxiety and depression among migraineurs. Insomnia, anxiety and depression are common complaints among migraineurs, and insomnia has been reported to be linked with anxiety and migraine. However, the association between insomnia, anxiety and depression in migraineurs has […]

Read more...

Can a Higher Chocolate Intake Lower Risk for Cardiovascular Disease, Stroke in Healthy Adults?

Chocolate lovers rejoice! More findings suggest that regular consumption of chocolate may decrease the risk of cardiovascular events and stroke in otherwise-healthy people. Analysis of almost 21,000 adults from the UK’s Epic-Norfolk study showed that those who ate the most chocolate had an 11% lower risk of developing coronary heart disease (CHD) and a 25% […]

Read more...

New Study Says Teens and Children Not Getting Optimal Care for Migraine Pain

A study presented last week at the 57th Annual Scientific Meeting of the American Headache Society has found that too many children suffering with migraines are not getting any medication for their pain and too few are receiving care consistent with evidence-based guidelines. “We discovered that the best care occurs for children diagnosed with migraine […]

Read more...

Study Finds Migraine Patients Skip Triptans in 40% of Attacks

Results from the largest-ever study to track real-time adherence to triptans during an extended time were presented at the American Headache Society 57th Annual Scientific Meeting. “We know that triptans work really well for a majority of patients with migraine. In this study, we found that those patients who can recognize their symptoms are best […]

Read more...

 


    • in an analysis of clinical trials, the most commonly prescribed group of migraine drugs failed to relieve headaches in 24% to 68% of attacks
    • The review found that all marketed tripants provided significant relief and/or absence of pain at 1 and 2 hours when compared with placebo. however, the analysis also showed that 24% to 68% of migranes failed to respond to these medications.